Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-24 Sale |
2025-03-26 4:47 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
6,000 | $50 | $300,000 | 877,741 (Indirect Direct) |
View |
| 2025-03-18 Sale |
2025-03-20 9:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
10,565 | $47.88 | $505,856 | 65,057 (Direct) |
View |
| 2025-03-18 Sale |
2025-03-20 9:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
7,583 | $47.89 | $363,142 | 79,682 (Direct) |
View |
| 2025-03-18 Sale |
2025-03-20 9:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
9,686 | $47.88 | $463,766 | 51,712 (Direct) |
View |
| 2025-03-18 Sale |
2025-03-20 9:48 pm |
Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer |
6,711 | $47.88 | $321,323 | 46,355 (Direct) |
View |
| 2025-03-18 Sale |
2025-03-20 9:48 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
24,216 | $48.03 | $1,163,050 | 883,741 (Indirect Direct) |
View |
| 2025-03-18 Sale |
2025-03-20 9:48 pm |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
3,724 | $47.88 | $178,306 | 22,431 (Direct) |
View |
| 2024-08-12 Sale |
2024-08-14 4:34 pm |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
35,000 | $26.08 | $912,961 | 279,552 (Indirect Direct) |
View |
| 2024-06-18 Sale |
2024-06-20 4:26 pm |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
10,445 | $27.47 | $286,924 | 101,780 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-17 Exercise |
2025-03-18 9:40 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
16,038 | $0 | 50,215 (Direct) |
View |
| 2025-03-15 Exercise |
2025-03-18 9:40 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
102,790 | $0 | 1,022,571 (Direct) |
View |
| 2025-03-15 Exercise |
2025-03-18 9:39 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer |
37,770 | $0 | 93,553 (Direct) |
View |
| 2025-03-15 Exercise |
2025-03-18 9:39 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
38,426 | $0 | 102,212 (Direct) |
View |
| 2025-03-15 Exercise |
2025-03-18 9:39 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
42,528 | $0 | 132,718 (Direct) |
View |
| 2025-03-15 Exercise |
2025-03-18 9:38 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
41,914 | $0 | 120,768 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-11 4:01 pm |
N/A 2032-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
7,000 | $0 | 13,350 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-11 4:01 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
7,000 | $12.89 | 13,350 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:20 pm |
N/A 2035-03-04 |
Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer |
50,717 | $0 | 50,717 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:19 pm |
N/A 2035-03-04 |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
50,717 | $0 | 50,717 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:19 pm |
N/A 2035-03-04 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
55,789 | $0 | 55,789 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:19 pm |
N/A 2035-03-04 |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
50,717 | $0 | 50,717 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:18 pm |
N/A 2035-03-04 |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
50,717 | $0 | 50,717 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:17 pm |
N/A 2035-03-04 |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
150,248 | $0 | 150,248 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:17 pm |
N/A 2035-03-04 |
Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer |
25,359 | $0 | 25,359 (Direct) |
View |
| 2024-11-13 Option Award |
2024-11-15 4:37 pm |
N/A 2034-11-12 |
Tarsus Pharmaceuticals Inc. | TARS | Goodrich Katherine Director |
16,700 | $0 | 16,700 (Direct) |
View |
| 2024-11-04 Option Award |
2024-11-06 4:40 pm |
N/A 2034-11-03 |
Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer |
68,352 | $0 | 68,352 (Direct) |
View |
| 2024-09-30 Gift |
2024-10-02 5:27 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Morrison Scott W Director |
6,016 | $0 | 6,016 (Direct) |
View |
| 2024-09-15 Exercise |
2024-09-17 5:52 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Morrison Scott W Director |
1,333 | $0 | 7,350 (Direct) |
View |
| 2024-08-12 Other |
2024-08-14 4:34 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
112,454 | $0 | 279,552 (Indirect) |
View |
| 2024-06-24 Exercise |
2024-06-25 6:26 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Crane Rosemary A Director |
3,350 | $0 | 5,350 (Direct) |
View |
| 2024-06-24 Exercise |
2024-06-25 6:26 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
3,350 | $0 | 6,350 (Direct) |
View |
| 2024-06-24 Exercise |
2024-06-25 6:25 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
3,350 | $0 | 139,982 (Direct) |
View |
| 2024-06-24 Exercise |
2024-06-25 6:24 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Director |
3,350 | $0 | 33,256 (Direct) |
View |
| 2024-06-24 Exercise |
2024-06-25 6:23 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Morrison Scott W Director |
3,350 | $0 | 4,683 (Direct) |
View |
| 2024-06-24 Exercise |
2024-06-25 6:22 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | CHAUDHURI BHASKAR Director |
3,350 | $0 | 5,350 (Direct) |
View |
| 2024-06-24 Exercise |
2024-06-25 6:21 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director |
3,350 | $0 | 10,350 (Direct) |
View |
| 2024-06-17 Exercise |
2024-06-20 4:26 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
27,881 | $0 | 101,780 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:45 pm |
N/A 2034-06-12 |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
8,350 | $0 | 8,350 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:44 pm |
N/A 2034-06-12 |
Tarsus Pharmaceuticals Inc. | TARS | CHAUDHURI BHASKAR Director |
8,350 | $0 | 8,350 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:40 pm |
N/A 2034-06-12 |
Tarsus Pharmaceuticals Inc. | TARS | Crane Rosemary A Director |
8,350 | $0 | 8,350 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:38 pm |
N/A 2034-06-12 |
Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director |
8,350 | $0 | 8,350 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:33 pm |
N/A 2034-06-12 |
Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Director |
8,350 | $0 | 8,350 (Direct) |
View |